3 commercial payer policies list C88.8. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
3 policies from 1 payer
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of C88.8 |
|---|---|---|
| Bortezomib Products | Feb 2, 2024 | Covered |
| Flow Cytometry, Ektacytometry, DNA Ploidy, and S-phase Fraction | Jun 5, 2023 | Covered |
| Plerixafor | Jan 9, 2024 | Covered |